JA
JLB & Associates Portfolio holdings
AUM
$717M
1-Year Return
13.62%
This Quarter Return
+8.91%
1 Year Return
+13.62%
3 Year Return
+68.06%
5 Year Return
+125.23%
10 Year Return
–
AUM
$237M
AUM Growth
+$17.9M
(+8.2%)
Cap. Flow
+$344K
Cap. Flow
% of AUM
0.15%
Top 10 Holdings %
Top 10 Hldgs %
29.98%
Holding
77
New
4
Increased
27
Reduced
36
Closed
4
Top Buys
| 1 |
NewMarket
NEU
|
$610K |
| 2 |
Amgen
AMGN
|
$575K |
| 3 |
TJX Companies
TJX
|
$523K |
| 4 |
Canadian National Railway
CNI
|
$396K |
| 5 |
Core Laboratories
CLB
|
$388K |
Top Sells
| 1 |
Lockheed Martin
LMT
|
$790K |
| 2 |
Polaris
PII
|
$720K |
| 3 |
Gilead Sciences
GILD
|
$592K |
| 4 |
Procter & Gamble
PG
|
$457K |
| 5 |
Clorox
CLX
|
$299K |
Sector Composition
| 1 | Technology | 18.18% |
| 2 | Consumer Discretionary | 17.52% |
| 3 | Healthcare | 17.36% |
| 4 | Industrials | 13.36% |
| 5 | Consumer Staples | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Silgan Holdings
SLGN
$4.77B
| $4.45M | 1.88% |
189,562
+5,990
| +3% | +$141K |
|
|
ALTR
27
DELISTED
ALTERA CORP
ALTR
| $4.43M | 1.87% |
119,290
-685
| -0.6% | -$25.5K |
|
|
28
TJX Companies
TJX
$157B
| $4.32M | 1.82% |
153,214
+18,550
| +14% | +$523K |
|
29
Cracker Barrel
CBRL
$1.15B
| $4.07M | 1.71% |
39,422
+378
| +1% | +$39K |
|
|
30
Amgen
AMGN
$150B
| $3.74M | 1.58% |
33,418
+5,139
| +18% | +$575K |
|
31
Kellanova
K
$27.6B
| $3.7M | 1.56% |
67,183
+21
| +0% | +$1.16K |
|
32
Copart
CPRT
$48B
| $3.64M | 1.53% |
914,896
-28,400
| -3% | -$113K |
|
33
Tapestry
TPR
$21.7B
| $3.37M | 1.42% |
61,892
+1,152
| +2% | +$62.8K |
|
34
Dollar Tree
DLTR
$20.1B
| $3.28M | 1.38% |
57,352
+315
| +0.6% | +$18K |
|
35
AbbVie
ABBV
$375B
| $3.14M | 1.32% |
70,098
+770
| +1% | +$34.4K |
|
|
COL
36
DELISTED
Rockwell Collins
COL
| $3.08M | 1.3% |
45,442
-847
| -2% | -$57.5K |
|
37
Expeditors International
EXPD
$16.4B
| $2.99M | 1.26% |
67,879
-2,500
| -4% | -$110K |
|
|
PDCO
38
DELISTED
Patterson Companies, Inc.
PDCO
| $2.78M | 1.17% |
69,254
-100
| -0.1% | -$4.02K |
|
39
Novo Nordisk
NVO
$251B
| $2.69M | 1.13% |
158,740
+6,320
| +4% | +$107K |
|
40
Danaher
DHR
$141B
| $2.61M | 1.1% |
56,088
-261
| -0.5% | -$12.2K |
|
41
Exxon Mobil
XOM
$481B
| $2.56M | 1.08% |
29,803
-175
| -0.6% | -$15.1K |
|
42
Abbott
ABT
$231B
| $2.54M | 1.07% |
76,503
+425
| +0.6% | +$14.1K |
|
43
IBM
IBM
$231B
| $2.48M | 1.05% |
14,022
-78
| -0.6% | -$13.8K |
|
44
Cisco
CSCO
$270B
| $2.34M | 0.98% |
99,694
-2,560
| -3% | -$60K |
|
45
Kimberly-Clark
KMB
$42.6B
| $2.15M | 0.9% |
23,760
-907
| -4% | -$81.9K |
|
46
Labcorp
LH
$22.8B
| $2.09M | 0.88% |
24,543
+349
| +1% | +$29.7K |
|
47
Mettler-Toledo International
MTD
$26.3B
| $1.82M | 0.77% |
7,585
-305
| -4% | -$73.2K |
|
|
48
Canadian National Railway
CNI
$60.3B
| $1.75M | 0.74% |
34,502
+7,820
| +29% | +$396K |
|
49
Eli Lilly
LLY
$669B
| $1.64M | 0.69% |
32,609
-300
| -0.9% | -$15.1K |
|
50
Bio-Techne
TECH
$8.23B
| $1.6M | 0.67% |
79,920
-800
| -1% | -$16K |
|